• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA clears OrthoAccel’s AcceleDent Optima

FDA clears OrthoAccel’s AcceleDent Optima

June 1, 2017 By Sarah Faulkner

OrthoAccel's AcceleDent OptimaOrthoAccel Technologies said today that the FDA approved its AcceleDent Optima device as the 1st and only connected orthodontic device that incorporates usage monitoring and direct messaging through the AcceleDent app.

The device is OrthoAccel’s 3rd-gen vibratory accelerated orthodontic product to be commercially available within the last 6 years. Optima is small, lightweight, waterproof and can connect with smartphones and tablets, according to the company.

Optima uses OrthoAccel’s SoftPulse technology to produce pulsating forces that stimulate cellular activity and speed up bone remodeling.

“I offer AcceleDent because the science supporting acceleration using low-pulsatile forces, such as those employed by AcceleDent, has existed for 40 years,” Dr. Straty Righellis said in prepared remarks. “AcceleDent Optima will make it easier for orthodontists to monitor and encourage patient compliance because of the usage data that syncs to the AcceleDent App.”

The AcceleDent App allows patients to track their usage and set reminder notifications. Orthodontists and healthcare practitioners can access real-time usage data for each of their AcceleDent patients through a customizable web portal.

“The benefit of integrating low-force pulsation, such as AcceleDent, as my sole accelerated treatment option is that it’s noninvasive, it gives me added control through all three stages of treatment and it does not disrupt the normal patient flow of my orthodontic office,” Righellis added.

AcceleDent Optima has also been cleared by Health Canada and has CE Mark approval in the European Union.

Filed Under: Dental, Food & Drug Administration (FDA), Regenerative Medicine Tagged With: OrthoAccel Technologies Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy